These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2290854)

  • 1. Activation and pulmonary toxicity of pyrrolizidine alkaloids.
    Huxtable RJ
    Pharmacol Ther; 1990; 47(3):371-89. PubMed ID: 2290854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
    Song Z; He Y; Ma J; Fu PP; Lin G
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
    Bruner LH; Carpenter LJ; Hamlow P; Roth RA
    Toxicol Appl Pharmacol; 1986 Sep; 85(3):416-27. PubMed ID: 3094196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA; Ganey PE
    Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Huxtable RJ; Bowers R; Mattocks AR; Michnicka M
    Adv Exp Med Biol; 1991; 283():605-12. PubMed ID: 1906228
    [No Abstract]   [Full Text] [Related]  

  • 6. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA; Reindel JF
    Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung.
    Lafranconi WM; Huxtable RJ
    Biochem Pharmacol; 1984 Aug; 33(15):2479-84. PubMed ID: 6087830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat.
    Yan CC; Huxtable RJ
    Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocrotaline pneumotoxicity in mice.
    Molteni A; Ward WF; Ts'ao CH; Solliday NH
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(3):149-55. PubMed ID: 2570481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
    Mattocks AR; Driver HE
    Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
    He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G
    Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
    Lalich JL; Johnson WD; Raczniak TJ; Shumaker RC
    Arch Pathol Lab Med; 1977 Feb; 101(2):69-73. PubMed ID: 138406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
    Mattocks AR; Bird I
    Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.